Skip to content

IRADIMED CORP

IRMD

CIK 0001325618

← back to feed
Revenue (TTM)
$83.1M
+14.4% YoY Q1 Apr 2026
Net Income (TTM)
$21.86M
+16.9% YoY Q1 Apr 2026
EPS Diluted (TTM)
$1.70
+16.7% YoY Q1 Apr 2026
Gross Margin
77.1%
Q1 Apr 2026
Operating Margin
31.6%
Q1 Apr 2026
Net Margin
26.3%
Q1 Apr 2026
Free Cash Flow (TTM)
$10.34M
Q1 Apr 2026
Cash
$56.37M
Q1 Apr 2026
Total Debt
—
Q1 Apr 2026
Shares Outstanding
12.78M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings